Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate

F Scott Heinemann1, Paul D Gershon2

  • 1Department of Pathology, Hoag Memorial Hospital Presbyterian, Newport Beach, California.

PubMed

Insights

Triple-negative breast cancer (TNBC) subtypes show distinct protein profiles in neoplastic cells. T-cell infiltrated TNBC overexpresses proteins involved in immune signaling and DNA damage response, unlike T-cell desert TNBC.

Area of Science:

  • Oncology
  • Immunology
  • Proteomics

Background:

  • The tumor microenvironment's influence on neoplastic cells in triple-negative breast cancer (TNBC) is not fully understood.
  • TNBC exhibits diverse immunotypes, including T-cell desert and T-cell infiltrated (TCI) subtypes.

Purpose of the Study:

  • To compare protein expression in neoplastic cells between T-cell desert and TCI TNBC immunotypes.
  • To identify proteins correlating with T-cell infiltration levels in TNBC.

Main Methods:

  • Label-free quantitative protein mass spectrometry on formalin-fixed, paraffin-embedded TNBC tissue sections.
  • Comparative proteomic analysis of 439 significantly differentially abundant proteins between TCI and T-cell desert TNBC.
  • Immunohistochemical validation of key differentially abundant proteins in a larger cohort of TNBC samples.

Main Results:

  • 361 proteins were significantly overabundant in TCI-TNBC compared to T-cell desert TNBC.
  • Overabundant proteins in TCI-TNBC are associated with MHC-I antigen processing, viral defense, DNA damage response, and innate immune signaling.
  • Elevated levels of interferon-γ-inducible protein 16, apoptosis-associated speck-like protein containing a CARD (ASC), and gasdermin D were observed in TCI-TNBC neoplastic cells.
  • Barrier to autointegration factor (BAF) was elevated in T-cell desert TNBC neoplastic cells.

Conclusions:

  • A novel correlation exists between T-cell infiltration levels in TNBC and the abundance of specific proteins within neoplastic cells.
  • These proteins modulate innate immune signaling pathways in response to DNA damage, offering potential therapeutic targets.